Angus Chen from STAT News - Journalist Profile

	Profile	Recent Articles on Subject
1	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: Growing number of federal health agencies are combing grants for taboo words, unnerving researchers - 9 days ago STAT+: Trump policies spark fears of brain drain, threatening to undermine U.S. dominance in biomedicine - 10 days ago The most essential and memorable JPM moments, recapped - about 1 month ago Beneath deal-making at J.P. Morgan conference, debate and sympathy over Americans’ anger at health care - about 1 month ago STAT+: Johnson & Johnson says its lung cancer drug significantly extended survival - about 2 months ago Why bone marrow transplants are becoming less common - 2 months ago STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - 2 months ago Biopharma leaders lay out vision for the future of blood cancer treatment - 3 months ago Using AI, images are fueling a new boom in cell biology - 4 months ago STAT+: Q&A: AI is coming for lots of jobs. What about that of the cancer researcher? - 5 months ago Blood cell counts have unfairly kept Black and Middle Eastern people from clinical trials, study says - 5 months ago Study exposes the dangerous ‘hidden’ mental burden of cancer on patients’ spouses - 6 months ago Bone marrow donors needn’t be perfect match, study says, paving way for more equitable access - 7 months ago CAR-T cell therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies - 8 months ago STAT+: ASCO preview: a promising solid tumor CAR-T, an AI patient navigator, and improving palliative care - 9 months ago STAT+: FDA advisers endorse Guardant Health’s colon cancer screening test - 9 months ago STAT+: When a cancer drug fails, oncologists often fly blind. A precision technique might light the way - 11 months ago STAT+: New liquid biopsy screening test for pancreatic cancer shows promise in early data - 11 months ago STAT+: Leading MD Anderson oncologist disputes junior scientist’s claims in lawsuit over research credit - about 1 year ago STAT+: In ‘major milestone,’ FDA approves first cell therapy for solid tumors - about 1 year ago STAT+: A flurry of research misconduct cases has universities scrambling to protect themselves - about 1 year ago STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit - about 1 year ago Quitting alcohol — or even drinking less — reduces risk of oral cavity and esophageal cancer, per new analysis - about 1 year ago STAT+: FDA alters warning label for Carvykti CAR-T, although link to secondary cancers is unclear - about 1 year ago STAT+: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients - about 1 year ago STAT+: CAR-T, recently used in a lupus patient, helps other autoimmune patients, too, in small study - about 1 year ago STAT+: Was CAR-T therapy a bystander or driver of lymphoma? Researchers examine first published case - about 1 year ago STAT+: Blood cancers may arise from CAR-T cells, but experts think only in very rare cases - about 1 year ago STAT+: Colon cancer prevention paradox: Higher-risk patients pay more for colonoscopy - about 1 year ago STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma - about 1 year ago Why do some CAR-T cancer patients have severe complications? Data points to latent virus - over 1 year ago American Cancer Society expands lung cancer screening guidelines for cigarette smokers - over 1 year ago Cancer disparities persisted even among clinical trial participants, study finds - over 1 year ago STAT+: Long underappreciated, gamma-delta T cells may be key to colon cancer defense, study says - over 1 year ago STAT+: Cancer drug shortages widen disparities between big systems and small - over 1 year ago
2	Usha Lee McFarling STAT News	STAT+: Growing number of federal health agencies are combing grants for taboo words, unnerving researchers - 9 days ago
3	Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia health policyjournalism	STAT+: Growing number of federal health agencies are combing grants for taboo words, unnerving researchers - 9 days ago
4	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: Trump policies spark fears of brain drain, threatening to undermine U.S. dominance in biomedicine - 10 days ago Biopharma leaders lay out vision for the future of blood cancer treatment - 3 months ago STAT+: FDA advisers endorse Guardant Health’s colon cancer screening test - 9 months ago STAT+: A flurry of research misconduct cases has universities scrambling to protect themselves - about 1 year ago STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit - about 1 year ago
5	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	The most essential and memorable JPM moments, recapped - about 1 month ago STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma - about 1 year ago
6	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	The most essential and memorable JPM moments, recapped - about 1 month ago
7	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Biopharma leaders lay out vision for the future of blood cancer treatment - 3 months ago
8	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Biopharma leaders lay out vision for the future of blood cancer treatment - 3 months ago
9	Alia Sajani STAT News	CAR-T cell therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies - 8 months ago
10	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma - about 1 year ago